A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Clinical trial NCT07111546 · RECRUITING

Trial details

NCT number: NCT07111546
Sponsor: Nanjing Leads Biolabs Co.,Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumour

Start date: 2025-10-20
Primary completion: 2027-12-26
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.